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We evaluated the effect of continuous low dose ketamine infusion combined with remifentanil and
propofol in patients undergoing laparoscopic gastric bypass, on hemodynamic stability, postoper-
ative analgesic requirement and recovery proﬁle.
Methods: 60 patients aged 25–50 years, allocated into 2 groups. Group I: received continuous infu-
sion of (propofol 6–10 mg/kg/h + remifentanil 0.2 lg/kg/min + saline). Group II: received contin-
uous infusion of (propofol 6–10 mg/kg/h + remifentanil 0.2 lg/kg/min+ ketamine 1lg/kg/min).
All patients recieved intravenous morphine by patient controlled analgesia (PCA) postoperatively.
Mean blood pressure and HR, duration of anesthesia and surgery recorded. Bispectral index, total
amount of propofol and remifentanil used intraoperative were measured. In the recovery room,
time to response to verbal commands was recorded, subjective pain scores were obtained with a
scale from 0–10. Postoperative nausea and vomiting, hallucinations were recorded. Early pain per-
ception and total consumption of morphine in 24 h recorded.
Results: During anesthesia, mean arterial blood pressure and heart rate were decreased in group I
compared with group II. The amount of propofol required to maintain the target BIS was lower in
group II compared with group I . The amount of intraoperative boluses of remifentanil required to.com (R. Hasanein).
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256 R. Hasanein et al.maintain hemodynamics was lower in group II compared with group I. The amount of PCA mor-
phine at 2 h in the PACU and the ﬁrst post operative day were lower in group II compared with
group I. Pain scores at 1 h and 2 h postoperatively were lower in group II compared to group I.
P value <0.05 was considered signiﬁcant.
Conclusion: During laparoscopic gastric bypass in morbidly obese patients the co-administration
of low dose ketamine and remifentanil by continuous infusion provide more hemodynamic stability,
satisfactory recovery proﬁle and adequate postoperative pain relieve.
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The increasing incidence of obesity is a growing problem in na-
tional health care, which causes an increase in bariatric surgery
[1]. Obese patients may be sensitive to respiratory depressant
effect of opioid analgesic drugs and are more likely to require
postoperative ventilation to avoid hypoxic episodes [2]. Remif-
entanil hydrochloride, an ultra-short acting mu opioid recep-
tor agonist, because of its ester structure, remifentanil is
submitted to wide spread ester hydrolysis, resulting in very ra-
pid metabolism [3]. It is now currently used with propofol as
total intravenous anesthesia (TIVA), it appears to produce
moderate to mild hypotension [4]. Also an important concern
with remifentanil is the possibility of acute opioid tolerance or
hyperalgesia that may increase postoperative pain [5]. Keta-
mine, a dissociative intravenous anesthetic. It was ﬁrst used
in human in 1965, it remains the subject of interest in clinical
investigations [6]. The choice of general anesthesia for obese
patients remains controversial [7].
The aim of this study was to evaluate the efﬁcacy of contin-
uous low dose ketamine infusion combined with remifentanil
and propofol infusion (TIVA) in patients undergoing laparo-
scopic Roux-en-Y gastric bypass (RYGBP), on hemodynamic
stability, postoperative analgesic requirement and recovery
proﬁle.2. Patients and methods
After approval of the local Ethics Committee and patients in-
formed written consent for elective laparoscopic Roux-en-Y
gastric bypass (RYGBP) surgery, 60 morbidly obese patients
(ASA physical status II or III), and age between 25 and
50 years, were enrolled in the study.
Patients with signiﬁcant cardiac, respiratory, brain, liver or
kidney diseases, or patients having allergy to the study drugs
or patients unable to use post operative PCA were excluded
from the study.
The patients were randomly allocated into two equal
groups. Group I: received continuous infusion of (propofol
6–10 mg/kg/h guided by the BIS + remifentanil 0.2 lg/kg/
min + saline). Group II: received continuous infusion of (pro-
pofol 6–10 mg/kg/h guided by the BIS + remifentanil 0.2 lg/
kg/min + ketamine 1 lg/kg/min). All patients were planned
to receive intravenous morphine patient controlled analgesia
(PCA) postoperatively. PCA morphine prepared by adding
30 mg morphine sulphate to 27 ml normal saline, total volume
30 ml at concentration 1mg/ml, no bolus injection, PCA bolus
1 ml, no background infusion, lockout period 10 min, total
amount of morphine in 4 h is 24 ml.Patients and investigators recording data in the operating
room were blinded to the treatment (ketamine or placebo),
but anesthesiologist were aware of the treatment condition.
All drug doses were used according to true patient weight.
In all patients antithrombotic treatment with low molecular
weight heparin was started 12 h before the procedure. All pa-
tients received midazolam 3 mg with glycopyrrolate 0.2 mg
intravenous bolus in the holding area.
In the operating room, standard monitors were applied:
ECG, non invasive blood pressure, pulse oximetry, EtCO2
(end tidal CO2), peripheral nerve stimulator, temperature
probe, spirometry, urinary catheter and BIS (bispectral analy-
sis of EEG, Aspect Medical, USA).
Before induction of anesthesia, patients received 10 mg
metoclopramide, 50 mg ranitidine, and 8 mg dexamethazone
i.v.
Anesthesia was induced after pre-oxygenation for 3 min by
face mask with 100% oxygen, by remifentanil (1 lg/kg), lido-
caine (100 mg), propofol (1–2 mg/kg), and cisatracurium to
facilitate endotracheal intubation (0.2 mg/kg).
The lungs were ventilated with a mixture of 50% air in oxy-
gen in the pressure control mode with positive end-expiratory
pressure (5–10 cm H2O) to maintain normocapnea (EtCO2 35–
40 mm Hg).
For maintenance of anesthesia, continuous infusion of pro-
pofol 6–10 mg/kg/h was started; the rate of propofol was chan-
ged to maintain the BIS between 40 and 55.
In group I: remifentanil infusion in dose of (0.2 lg/kg/min)
was added.
In group II: combined infusion of remifentanil (0.2 lg/kg/
min) + ketamine (1 lg/kg/min) were added.
Cisatracurium given to all patients by boluses to maintain
muscle relaxation (0.03 mg/kg) every 20–40 min based on neu-
romuscular stimulation.
All patients received a total volume of infusion of 3–4 L of
Ringer’s Lactate solution during anesthesia.
The infusions of both remifentanil, saline in (group I) and
remifentanil, ketamine in (group II) were continued till re-
moval of laparoscopy ports.
Patients were placed in the supine position. Laparoscopic
RYGBP was performed through ﬁve abdominal trocars. In-
tra-abdominal pressure was maintained at 15 mm Hg.
At the end of surgery, anesthesia was maintained at a con-
stant level during closure of the surgical incisions until the last
stitch was completed.
Propofol was then turned off and the time to safe extuba-
tion was recorded. At the end of the operation muscle relaxant
was reversed based on peripheral nerve stimulation. The extu-
bation was performed when the patient gained 80% on Train-
of-four stimulation. All patients were extubated and sent to
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monitoring of the vital signs were applied: ECG, non invasive
blood pressure, pulse oximetry, 2–3 L/min oxygen by nasal
cannula were applied to all patients.
In the recovery room, time to response to verbal commands
was recorded, subjective pain scores were obtained with a scale
from 0 to 10, with 0 = no pain and 10 = worst pain, at 1 and
2 h post operatively by a nurse blinded to the study protocol.
Morphine patient controlled analgesia (PCA) was started
once the patient pain score recorded 1–2 and continued in
the ward for 24 h postoperative.
Patients were encouraged to ambulate in the ﬁrst post oper-
ative day. Post operative pulmonary care included incentive
spirometry and deep breathing exercises were encouraged.Table 1 Patient age, weight, height, body mass index, ASA
physical status and duration of the procedure in minutes
(mean ± SD).
Group I (n= 30) Group II
Age (y) 27 ± 8 29 ± 6
Weight (kg) 119 ± 14 121 ± 19
Height (cm) 160 ± 5 162 ± 7
BMI (kg/m2) 40 ± 7 42 ± 4
Sex (M/F) 17/13 15/15
ASA (PS) II (20), III (10) II (18), III (12)
Duration of the procedure (min) 159 ± 27 156 ± 31
ASA (PS) = ASA physical status; BMI = body mass index.
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1103. Measurements
Mean blood pressure (mm Hg) and HR (beats/min) were mea-
sured before induction and every 5 min during surgery (re-
corded data T0: preoperative measures, T1 immediately after
induction, T2: 5 min after induction, T3: 10 min after induc-
tion, T4: 15 min after induction, T5: 30 min after induction,
T6: 60 min after induction, T7: 90 min after induction, T8:
2 h after induction, T9: 1st postoperative hour, T10: 2nd post-
operative hour, T11: 6 h post operative, T12: 12 h post opera-
tive). Duration of anesthesia and surgery (min) were recorded.
Bispectral index, total amount of propofol used (mg) and total
amount remifentanil used intraoperative were measured every
hour. Total amount of morphine used in the 24 h postopera-
tive period was calculated. The recovery proﬁle after anesthe-
sia including: time to spontaneous respiration, adequacy of
respiration (Negative Inspiratory Force (NIF) > 50 CmH2O,
tidal volume > 500 ml, saturation on O2 > 98%) was
recorded.
The incidence of postoperative nausea and vomiting
(PONV), hallucinations were recorded and managed
accordingly.
Early pain perception was measured by the time that passed
between extubation and the ﬁrst request of PCA (min). The
outcome was the consumption of morphine by intravenous
titration and by PCA during the ﬁrst 4 h after surgery.
Prolonged perception of pain was measured by patients’ total
consumption of morphine (mg) in 24 h.T0 T1 Tt2 T3 T4 T5 T6 T7 T8 T9 T10 T11 T12
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804. Statistical analysis
Data were expressed as mean ± standard deviation. Student’s
t test was used for each measurement within and between
group comparisons. Pain score and the incidence of side effects
were compared using Chi square test. P value of <0.05 was
considered signiﬁcant. All statistical analysis were done using
Excel and SPSS package.Figure 1 Mean arterial blood pressure changes (mm Hg) in both
groups, intraoperative and postoperative. *P value <0.05 in group
2 compared to group 1. t0: preop data, t1: immediately after
induction, t2: 5 min after, t3: 10 min after induction, t4: 15 min
after induction, t5:30 min, t6: 60 min, t7: 90 min, t8: 2 h, t9: 1st
postoperative hour, t10 2nd hour postoperative, t11: 6 h postop-
erative, t12: 12 h postoperative. T0, T1: not signiﬁcant, T2–T7:
signiﬁcant, T8–T12: lower in Group1 but not signiﬁcant.5. Results
Sixty patients were enrolled in the study with no exclusion. Pa-
tients demographic data are shown in Table 1. There were no
differences in age, weight, height, body mass index, sex, ASA
physical status or the duration of the operation between the
two groups.During anesthesia, mean arterial blood pressure (Fig. 1)
and heart rate (Fig. 2) were signiﬁcantly decreased in group I
compared with group II, P< 0.05.
The total amount of propofol required to maintain the tar-
get BIS was signiﬁcantly lower in group II compared with
group I, P< 0.05.
The total amount of intra-operative boluses of remifentanil
required to maintain hemodynamic was signiﬁcantly lower in
group II compared with group I.
The total amount of PCA morphine at 2 h in the PACU
and the ﬁrst post operative day were signiﬁcantly lower in
group II compared with group I.
Pain scores at 1 h and 2 h postoperatively were signiﬁcantly
lower in group II compared to group I.
Blood pressure and heart rate at 1 h and 2 h postoperatively
were clinically lower in group I compared to group II, but
these differences were statistically not signiﬁcant (Table 2).
Recovery proﬁle, duration to spontaneous respiration, ade-
quate respiration and safe extubation were shorter in group I
compared to group II .These duration were statistically
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Figure 2 Mean heart rate changes (beats/min) in both groups,
intra-operative and postoperative. *P value <0.05 in group 2
compared to group 1. t0: preop data, t1: immediately after
induction, t2: 5 min after, t3: 10 min after induction, t4: 15 min
after induction, t5: 30 min, t6: 60 min, t7: 90 min, t8: 2 h, t9: 1st
postoperative hour, t10 2nd hour postoperative hour, t11: 6 h
postoperative, t12: 12 h postoperative. T0, T1: not signiﬁcant, T2–
T7: signiﬁcant, T8–T12: lower in Group1 but not signiﬁcant.
Table 2 Measurements made at the end of surgery
(mean ± SD).
Group I
(n= 30)
Group II
(n= 30)
PACU pain score (0–10) 1 h 6 (4–8) 3 (1–2)*
PACU pain score (0–10) 2 h 5 (2–5) 2 (1–3)*
PACU morphine (mg, 2 h) 10.4 ± 1.4 6.3 ± 10.6*
Total amount of morphine
(mg), ﬁrst 24 h postoperatively
47.4 ± 8 6.1* ± 40
PACU mean blood
pressure (mm Hg/h)
90 ± 1 77 ± 9
PACU heart rate (min/h) 91 ± 4 83 ± 4
Total amount of intra-operative
remifentanil (lg)
350.5 ± 54.6 201.4 ± 54.3*
Total amount of intra-operative
propofol (mg)
2200 ± 450 1503 ± 311*
* P< 0.05 in group II compared to group I.
Table 3 Recovery proﬁle in minutes (mean ± SD).
Group I (n= 30) Group II (n= 30)
Response to verbal commands 3.4 ± 1.2 4.1 ± 0.7
Spontaneous respiration 4.6 ± 1 5.1 ± 0.5*
Adequate respiration 6.1 ± 1.5 6.3 ± 0.7
Safe extubation 7.5 ± 1.3 7.1 ± 0.7
* P< 0.05 in group II compared to group I.
Table 4 Incidence of side effects in both groups.
Group I (n= 30) Group II (n= 30)
No nausea and vomiting 27 (90%) 28 (93.4%)
Nausea 3 (10%) 2 (6.6%)
Vomiting 0 (0%) 0 (0%)
Hallucination 0 (0%) 0 (0%)
Data are presented as numbers (percentage).
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duration started from end of surgery and discontinuation of
propofol infusion (Table 3).
All patients after extubation were fully awake.
No differences in the incidence of postoperative nausea and
vomiting or hallucination between both groups (Table 4).
6. Discussion
The problem of postoperative respiratory complications in ob-
ese patients is magniﬁed by the use of narcotics during surgery
and postoperative for pain control [8].
Opioids can cause pronounced respiratory complications in
obese patients with obstructive sleep apnea.
Theoretically, co-administration of an opiate and ketamine
decreases the doses needed for optimal analgesia below therequired value of opioids when used alone and hence may
decreases the incidence of side effects.
The results of our study showed that, ketamine (1 lg/kg/
min) when added to propofol-remifentanil during laparoscopic
RYGBP, counteracted the hemodynamic changes induced by
remifentanil, decreased propofol consumption, decreased pain
score in the postoperative period, decreased morphine PCA
consumption and also resulted in a better recovery proﬁle than
using remifentanil-propofol alone.
Ketamine-related side effects such as hallucinations,
unpleasant dreams, and delirium did not occur in our patients,
as we used low dose continuous infusion, such side effects have
been related to large doses used for general anesthesia.
In the group received remifentanil alone patients developed
hypotension and bradycardia most probably due to
remifentanil.
Previous studies have shown an unacceptable incidence of
bradycardia associated with the use of remifentanil in the ab-
sence of a vagolytic agent [9]. However, opioid-induced brady-
cardia is gradually accepted to be vagally mediated [10].
It could be due to the impairment of baroreﬂex regulatory
mechanisms caused by propofol infusion [11].
Hypertension and bradycardia have been found with the
use of remifentanil when combined with intravenous agent
[12] or general anesthetics [13].
In contrast, to these results Glass et al. found increased
arterial blood pressure and heart rate after injecting remifenta-
nil intravenously alone without any other agents, in healthy
un-premeditated volunteers [14].
Degaute et al. found that remifentanil hydrochloride causes
consistent and maintained hypotension [15].
Sammons, AW et al. found profound hypotension caused
by remifentanil when compared to fentanyl used for day case
microlaryngoscopy [16].
In our study, in the ketamine-remifentanil group the heart
rate and mean arterial blood pressure did not decrease below
the preoperative values, most probably due to the catechol-
amine release of ketamine, which is commonly resulting in
both tachycardia and hypertension [17], an action that can
attenuate remifentanil effects.
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alfentanil with ketamine resulted in obtunding the tachycardia
and hypertension caused by ketamine after intubation and lit-
tle or no change in HR or ABP [18].
In the postoperative period, the hemodynamic measure-
ments were maintained within normal values in the keta-
mine-remifentanil group, while in the patients received
remifentanil alone there was slight increase in mean blood
pressure, which could be explained by the counteracting effect
of ketamine on remifentanil induced hyperalgesia.
Regarding recovery from anesthesia, the remifentanil group
patient recovered quicker than ketamine-remifentanil group,
although it was statistically signiﬁcant; clinically it was not sig-
niﬁcant. This is due to the short half-life of remifentanil which
is 8–10 min [14]. The presence of an ester side chain allow rapid
breaking down of remifentanil by non-speciﬁc estrases to
nearly inactive metabolites, causing rapid recovery from intra-
operative infusion [19].
The time to the ﬁrst PCA dose required in the PACU, was
shorter in the remifentanil group than in the ketamine-remifen-
tanil group, this could be due to the hyperalgesia and the
development of opioid-induced tolerance related to remifenta-
nil infusion. This is due to the activation of N-methyl-D-aspar-
tate (NMDA) receptors in the CNS, and subsequent
biochemical process leading to central sensitization, increase
spinal dynorphin activity and activation of intracellular pro-
tein kinase C29 [20].
Ketamine, a NMDA receptor antagonist used in the keta-
mine-remifentanil group may substantially enhance opiate-in-
duced anti-nociception [20].
Frederic Adam and his colleagues [21], evaluated the effect
of 1.5 lg/kg/min ketamine for postoperative pain relieve and
total consumption of morphine after total knee arthroplasty.
They found that ketamine group required less morphine than
the control group which helped in early knee mobilization.
Subra Maniam [22], concluded that the addition of keta-
mine either intravenous bolus or continuous infusion is more
effective than morphine alone, while intravenous PCA of ket-
amine and morphine was not more effective than intravenous
PCA morphine alone.
The result of the present study showed that continuous in-
tra-operative infusion of low dose ketamine combined with
remifentanil resulted in less postoperative pain score and less
morphine consumption than using remifentanil infusion alone.
Ketamine may produce its anti-nociception by activation of
the descending pain inhibitory mono-aminergic pathways
[23], which is expressed by alpha-2-adrenoceptor at the spinal
level [24]. Although anti-nociception of ketamine intra-thecal
in rats is reversed by naloxone [23], analgesia in humans by
systemic ketamine up to 300 lg/kg, cannot be reversed [25],
which means that mono-aminergic activation, more than the
mu receptor agonist activity, may be present in the anti-noci-
ception effect produced by the analgesic dose of ketamine.
The afﬁnity of ketamine for NMDA receptors is more than
an order of magnitude higher than that for mu receptors [25]
and several-fold higher than that for monoamine transporter
sites or other non-NMDA receptors (i.e. Acetylcholinestrase
and the epsilon receptors) [26], suggesting that the smaller
the dose, the more selective is the ketamine interaction with
NMDA receptors.
In consistent of our study Stubhug et al., showed that in hu-
man continuous infusion of small-dose ketamine for 48 h,increases the time for ﬁrst use PCA-morphine and reduced
cumulative morphine [27].
Other studies have found that a marked decrease in con-
sumption of opiate and/or pain intensity by systemic [28]
or epidural [29] co-administration of ketamine and
opiates.
In conclusion, our results demonstrated that during lapa-
roscopic RYGBP in morbidly obese patients the co-adminis-
tration of low dose ketamine and remifentanil by continuous
infusion provide more hemodynamic stability, satisfactory
recovery proﬁle and adequate postoperative pain relieve.References
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